Endothelial to mesenchymal transition in atherosclerotic vascular remodeling

Clin Chim Acta. 2019 Mar:490:34-38. doi: 10.1016/j.cca.2018.12.018. Epub 2018 Dec 17.

Abstract

Endothelial cells are the main components of the heart, blood vessels, and lymphatic vessels, which play an important role in regulating the physiological functions of the cardiovascular system. Endothelial dysfunction is involved in a variety of acute and chronic cardiovascular diseases. As a special type of epithelial-mesenchymal transition (EMT), endothelium to mesenchymal transition (EndMT) regulates the transformation of endothelial cells into mesenchymal cells accompanied by changes in the expression of various transcription factors and cytokines, which is closely related to vascular endothelial injury, vascular remodeling, myocardial fibrosis and valvar disease. Endothelial cells undergoing EndMT lose their endothelial characteristics and undergo a transition toward a more mesenchymal-like phenotype. However, the molecular mechanism of EndMT remains unclear. EndMT, as a type of endothelial dysfunction, can cause vascular remodeling which is a major determinant of atherosclerotic luminal area. Therefore, exploring the important signaling pathways in the process of EndMT may provide novel therapeutic strategies for treating atherosclerotic diseases.

Keywords: Atherosclerosis; Endothelial cell; Endothelial to mesenchymal transition; Vascular remodeling.

Publication types

  • Review

MeSH terms

  • Atherosclerosis / complications
  • Atherosclerosis / metabolism
  • Atherosclerosis / pathology*
  • Atherosclerosis / physiopathology
  • Epithelial-Mesenchymal Transition*
  • Humans
  • Neovascularization, Pathologic / complications
  • Transforming Growth Factor beta / metabolism
  • Vascular Remodeling*

Substances

  • Transforming Growth Factor beta